Stockwatch: Runners And Riders In The Coronavirus Stakes
Generalist Investors Among Possible Losers In The Pandemic
With so many companies developing treatments and vaccines against coronavirus, and most other affected by the pandemic, they can’t all be winners.
You may also be interested in...
Progress for two US-based companies in the race to develop a COVID-19 vaccine.
An official announcement is expected within weeks, as competition between US and China stokes fears of 'vaccine nationalism'.
It takes a lot of negotiation with regulators, advisory boards, and alignment between commercial and portfolio management teams to define and agree a clinical trial protocol. Why on earth would companies change it once a study is underway?